---
title: "Bromocriptine - Postencephalitic parkinsonism"
sidebar: mydoc_sidebar
permalink: db01200-mesh-d010301-1.html
toc: false 
---


Path ID: `DB01200_MESH_D010301_1`
{% include image.html url="images/db01200-mesh-d010301-1.png" file="db01200-mesh-d010301-1.png" alt="db01200-mesh-d010301-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D001971 | bromocriptine | Drug |
| UniProt:P14416 | Dopamine D2 receptor | Protein |
| UniProt:P35462 | Dopamine D3 receptor | Protein |
| MESH:D004298 | dopamine | ChemicalSubstance |
| UBERON:0035999 | dopaminergic cell groups | GrossAnatomicalStructure |
| UBERON:0002038 | substantia nigra | GrossAnatomicalStructure |
| UBERON:0014169 | nigrostriatal tract | GrossAnatomicalStructure |
| MESH:D010301 | Postencephalitic parkinsonism | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Bromocriptine | POSITIVELY REGULATES | Dopamine D2 Receptor |
| Bromocriptine | POSITIVELY REGULATES | Dopamine D3 Receptor |
| Dopamine D2 Receptor | POSITIVELY CORRELATED WITH | Dopamine |
| Dopamine D3 Receptor | POSITIVELY CORRELATED WITH | Dopamine |
| Dopamine | LOCATED IN | Dopaminergic Cell Groups |
| Dopaminergic Cell Groups | LOCATED IN | Substantia Nigra |
| Substantia Nigra | PARTICIPATES IN | Nigrostriatal Tract |
| Nigrostriatal Tract | AFFECTED BY | Postencephalitic Parkinsonism |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB01200#BE000058](https://go.drugbank.com/drugs/DB01200#BE000058)
  - [https://en.wikipedia.org/wiki/Postencephalitic_parkinsonism#:~:text=the%20free%20encyclopedia-,Postencephalitic%20parkinsonism,degeneration%20leads%20to%20clinical%20parkinsonism](https://en.wikipedia.org/wiki/Postencephalitic_parkinsonism#:~:text=the%20free%20encyclopedia-,Postencephalitic%20parkinsonism,degeneration%20leads%20to%20clinical%20parkinsonism)
